Faes Farma saw no growth in patent filings and highest growth of 2.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 2.99%. GlobalData’s DataBook provides a comprehensive analysis of Faes Farma’s patent filings and grants. Buy the databook here.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Faes Farma has been focused on protecting inventions in Chile(CL) with one publication in Q2 2024
The Chile(CL) Patent Office dominates the patent filings with nearly 100% of filings. The Chile(CL), European Patent Office(EPO), Spain(ES), and Poland(PL) patent Office are among the top ten patent offices where Faes Farma is filings its patents. Among the top granted patent authorities, Faes Farma has 33% of its grants in European Patent Office(EPO), 33% in Spain(ES) and 33% in Poland(PL).
Roche could be the strongest competitor for Faes Farma
Patents related to climate change lead Faes Farma's portfolio
Faes Farma has the highest number of patents in climate change. For climate change no patents were filed and 100% of patents were granted in Q2 2024.
Petrochemicals related patents lead Faes Farma portfolio followed by manufacturing/industrial, and cosmetics & toiletries
Faes Farma has highest number of patents in petrochemicals followed by manufacturing/industrial, cosmetics & toiletries, skincare, and anti-agers.
For comprehensive analysis of Faes Farma's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

